+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vitro antimicrobial activity against 10 North American and European Lawsonia intracellularis isolates



In vitro antimicrobial activity against 10 North American and European Lawsonia intracellularis isolates



Veterinary Microbiology 134(3-4): 305-310



The objective of this study was to determine the in vitro minimum inhibitory concentration (MIC) of antimicrobials against 10 isolates of Lawsonia intracellularis, the etiological agent of proliferative enteropathy (PE). Antimicrobials tested included carbadox, chlortetracycline, lincomycin, tiamulin, tylosin and valnemulin. The MIC of each antimicrobial against L. intracellularis was determined using a tissue culture system and was identified as the lowest concentration that inhibited 99% of L. intracellularis growth, as compared to the antimicrobial-free control. Each antimicrobial concentration was evaluated for both intracellular and extracellular activity against L. intracellularis, an obligately intracellular bacterium. When tested for intracellular activity, carbadox, tiamulin, and valnemulin were the most active antimicrobials with MICs of < or =0.5microg/ml. Tylosin (MICs ranging from 0.25 to 32microg/ml) and chlortetracycline (MICs ranging from 0.125 to 64microg/ml) showed intermediate activities and lincomycin (MICs ranging from 8 to >128mIcog/ml) showed the least activity. When tested for extracellular activity, valnemulin (MICs ranging from 0.125 to 4microg/ml) was the most active against most L. intracellularis isolates. Chlortetracycline (MICs ranging from 16 to 64microg/ml), tylosin (MICs ranging from 1 to >128microg/ml), and tiamulin (MICs ranging from 1 to 32microg/ml) showed intermediate activities. Lincomycin (MICs ranging from 32 to >128microg/ml) showed the least activity. Our in vitro results showed that each L. intracellularis isolate had a different antimicrobial sensitivity pattern and these data can be utilized as an in vitro guideline for the further antimicrobial evaluation of field L. intracellularis isolates.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053770838

Download citation: RISBibTeXText

PMID: 18823723

DOI: 10.1016/j.vetmic.2008.08.007


Related references

In vitro antimicrobial activity against equine Lawsonia intracellularis strains. Equine Veterinary Journal 2019, 2019

United States isolates of Lawsonia intracellularis from porcine proliferative enteropathy resemble European isolates. Swine Health and Production 4(3): 119-122, 1996

Antimicrobial susceptibility testing of two Lawsonia intracellularis isolates associated with proliferative hemorrhagic enteropathy and porcine intestinal adenomatosis in South Korea. Antimicrobial Agents and ChemoTherapy 55(9): 4451-4453, 2012

Isolation and in vitro antimicrobial susceptibility of porcine Lawsonia intracellularis from Brazil and Thailand. Bmc Microbiology 19(1): 27, 2019

Lawsonia intracellularis infection in horses. Literature review and case report FT Lovak Lawsonia intracellularis fertozese - Irodalmi attekintes es esetismertetes. 2008

Examinations on the incidence of Lawsonia intracellularis and about FT Vingalatok a Lawsonia intracellularis elterjedtsegerol es a fertozotottseget befolyasolo tenyezokrol. 2007

In vitro activity of four antimicrobial agents against North American isolates of porcine Serpulina pilosicoli. Journal of Veterinary Diagnostic Investigation 10(4): 350-356, 1998

Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents. Official Gazette of the United States Patent & Trademark Office Patents 1220(4): 3512, March 23, 1999

In vitro activity of the chicken egg antibody (IGY) against Lawsonia intracellularis. Thai Journal of Veterinary Medicine 37(1): 113, 2007

Evaluation of in vitro bactericidal activity of commercial disinfectants against Lawsonia intracellularis. Journal Of Swine Health And Production: 1, 11-17, 2010

Molecular typing of equine Lawsonia intracellularis isolates. Journal of Equine Veterinary Science 32(10): S32-S33, 2012

Diagnosis of Lawsonia intracellularis infection in pigs after vaccination or antimicrobial treatment. DeutscheDeutscheDeutsche Tierärztliche Wochenschrift/Tierärztliche RundschauTierärztlicheDeutsche Tierärztliche Wochenschrift/Tierärztliche RundschauWochenschrift/TierärztlicheDeutsche Tierärztliche Wochenschrift/Tierärztliche RundschauRundschauTierärztlicheDeutscheDeutsche Tierärztliche Wochenschrift/Tierärztliche RundschauTierärztlicheDeutsche Tierärztliche Wochenschrift/Tierärztliche RundschauWochenschrift/TierärztlicheDeutsche Tierärztliche Wochenschrift/Tierärztliche Rundsc, 2008

Species-specificity of equine and porcine Lawsonia intracellularis isolates in laboratory animals. Canadian Journal of Veterinary Research 77(4): 261-272, 2014

Patterns of exposure to Lawsonia intracellularis infection on European pig farms. Veterinary Record 152(1): 14-17, 2003

Activity of GAR-936 and other antimicrobial agents against North American isolates of Staphylococcus aureus. International Journal of Antimicrobial Agents 20(3): 220-222, 2002